iMR Lab at the Dickinson Image-Guided Intervention Center 22 September 2026 – Minneapolis, MN, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that Rady Children’s Hospital-San Diego has become the first commercial U.S. hospital customer, marking the commencement of the company’s U.S. commercial launch of Imricor Cardiovascular. This milestone marks the start … Read More
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
The solution combines Philips’ high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imricor’s exclusive portfolio of systems and consumables for MR-guided cardiac interventions. 27 August 2026 – Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional … Read More
Imricor Supports HRS Call for Enhanced Radiation Protection and Urges a Future Beyond Radiation Exposure
24 August 2026 – Minneapolis, MN, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), the pioneer in the interventional magnetic resonance (iMR) field, welcomed the Heart Rhythm Society’s call for the urgent and immediate adoption of enhanced radiation-protection measures for clinicians and staff working in fluoroscopy-based procedure environments.1 Imricor supports the use of enhanced radiation protection … Read More
Imricor Launches Imricor Cardiovascular, Opening New U.S. Market for Radiation-Free Cardiac Catheterization
3 August 2026 – Minneapolis, MN, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the launch of Imricor Cardiovascular, a new vertical that expands the interventional MR (iMR) market for Imricor alongside its electrophysiology and ablation business. Following recent FDA clearances for NorthStar® and the Vision-MR® Diagnostic Catheter, Imricor Cardiovascular gives U.S. … Read More
Imricor Receives FDA Clearances for NorthStar and Diagnostic Catheter for Pediatric Use
8 July 2026 – Minneapolis, MN, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for pediatric use of its NorthStar®, along with its Vision-MR® Diagnostic Catheter. These clearances expand the use of Imricor’s interventional magnetic resonance (iMR) technology to patients of all … Read More
NorthStar Mapping System Now Commercially Available in the United States
23 April 2026 – Minneapolis, MN – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings the … Read More
FDA Clears NorthStar Mapping System
2 February 2026 – Minneapolis, MN, Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for the Company’s NorthStar® Mapping System under the premarket notification process. NorthStar is the first and only MRI-Native 3D mapping and guidance system to receive FDA clearance, setting a new standard … Read More
FDA Clears Vision-MR Diagnostic Catheter
12 January 2026 – Minneapolis, MN, Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for the Company’s Vision-MR® Diagnostic Catheter under the premarket notification process. This marks the Company’s first FDA clearance. The Vision-MR Diagnostic catheter is designed to be used under … Read More
Imricor to Be Featured on CNBC’s Now We Know! with Steve Guttenberg
The upcoming episode of Now We Know! with Steve Guttenberg, aired Saturday, December 13 on CNBC, viewers will be introduced to Imricor, a pioneer in MRI-guided cardiac ablation technology. The Now We Know! crew visited Imricor’s headquarters in Minneapolis, Minnesota, to learn how the company is advancing electrophysiology with real-time MRI imaging. The segment also features insights from physicians at … Read More
First In Human Ischemic VT Ablation Successfully Performed in iCMR
4 November 2025 – Minneapolis, MN, Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic Ventricular Tachycardia (VT) ablation ever performed under real-time MRI guidance in an iCMR lab. Amsterdam UMC team, shown here, performed the VT ablation procedure following previous … Read More